Quest Diagnostics Incorporated (DGX) |
| 194.9 -1.3 (-0.66%) 05-29 16:00 |
| Open: | 196.59 |
| High: | 197.3799 |
| Low: | 194.295 |
| Volume: | 623,162 |
| Market Cap: | 21,575(M) |
| PE Ratio: | 21.56 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Diagnostics & Research |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 233.68 |
| Resistance 1: | 200.07 |
| Pivot price: | 191.58 |
| Support 1: | 191.52 |
| Support 2: | 186.23 |
| 52w High: | 213.5 |
| 52w Low: | 164.65 |
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
| EPS | 9.050 |
| Book Value | 66.360 |
| PEG Ratio | 1.45 |
| Gross Profit | 33.875 |
| Profit Margin (%) | 9.08 |
| Operating Margin (%) | 14.20 |
| Return on Assets (ttm) | 6.3 |
| Return on Equity (ttm) | 14.5 |
Fri, 29 May 2026
Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Thu, 28 May 2026
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock - Yahoo Finance
Tue, 26 May 2026
Quest Diagnostics Inc. stock outperforms competitors despite losses on the day - MarketWatch
Tue, 26 May 2026
Are Medical Stocks Lagging Quest Diagnostics (DGX) This Year? - Yahoo Finance
Mon, 25 May 2026
Quest Diagnostics Stock: Analyst Estimates & Ratings - Barchart.com
Thu, 21 May 2026
Director at Quest Diagnostics (NYSE: DGX) receives 1,142 RSUs - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |